MentionFox
Home › Executive changes › Dynavax Technologies Corp
Leadership changes · DVAX · SEC Form 8-K, Item 5.02

Leadership changes at Dynavax Technologies Corp (2026)

Before you join, sell to or invest in Dynavax Technologies Corp

MentionFox check on Dynavax Technologies Corp: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/dynavax-technologies

Check Dynavax Technologies Corp before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Dynavax Technologies Corp?

Who joined and who left Dynavax Technologies Corp (DVAX)? 1 filing reported on 2026-02-10, each cited to the company's own filing.

As of November 14, 2026, Dynavax Technologies Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 10, 2026 (Form 8-K, February 10, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Deep Track Biotechnology Master Fund, Ltd. also filed stake reports on 60 other companies ↓

Sell to companies like Dynavax Technologies Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-02-10

Dynavax Technologies Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-10. Every row below is cited to the filing it comes from, and this page adds each new change as Dynavax Technologies Corp files it.

Also on the record for Dynavax Technologies Corp

DateRecordFigureOur pageSource
February 11, 2026Stake report, Schedule 13G/A, by Deep Track Capital, LP—5%+ stakesSource
August 25, 2025Stake report, Schedule 13G/A, by Deep Track Biotechnology Master Fund, Ltd.13.41% of the class5%+ stakesSource
July 17, 2025Stake report, Schedule 13G/A, by BlackRock, Inc.14.2% of the class5%+ stakesSource

Selling to them or working with them? See who runs Dynavax Technologies Corp now and the warning signs.

Free to see. No signup.

Keep reading

More on Dynavax Technologies Corp and the records around it.

Companies that share a holder

Want the whole picture on Dynavax Technologies Corp?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Dynavax Technologies Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Dynavax Technologies Corp covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-10Reportednot named in the filing8-K, 2026-02-10
Selling to Dynavax Technologies Corp?

New leaders reset buying decisions — get the Full Report on Dynavax Technologies Corp: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Dynavax Technologies Corp

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Dynavax Technologies Corp, with the record behind each one.

Find candidates like senior executive at Dynavax Technologies Corp

Every change, in the filing's words

Filed 2026-02-10 · 8-K

Reported

Directors Effective as of the Effective Time, each of the directors of the Company (Scott Myers, Ryan Spencer, Daniel L. Kisner, M.D., Lauren Silvernail, Brent MacGregor, Elaine Sun, Francis R. Cano, Ph.D., Peter R. Paradiso, Ph.D. and Emilio Emini, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.

Also stated in this filing

  • As of the Effective Time, in accordance with the Merger Agreement, the sole director of Purchaser as of immediately prior to the Effective Time, Fran ois-Xavier Dazogbo, became the sole director of the Company.
  • After the Effective Time, Genzyme Corporation, as sole stockholder of the Company, passed resolutions appointing Thomas Grenier and Colleen Proctor as the sole directors of the Company.
  • Officers Effective as of the Effective Time the sole officer of Purchaser as of immediately prior to the Effective Time, Fran ois-Xavier Dazogbo, became the sole officer of the Company.
  • After the Effective Time, Fran ois-Xavier Dazogbo, as sole director of the Company, passed resolutions appointing (or confirming the appointment of) the following individuals as officers of the Company: (i) Ryan Spencer, Chief Executive Officer, (ii) David F. Novack, President and Chief Operating Officer, (iii) Kelly MacDonald, Senior Vice President and Chief Financial Officer, (iv) John L. Slebir, Senior Vice President, General Counsel and Secretary, (v) Jamie Haney, Secretary, (vi) Fran ois-Xavier Dazogbo, Treasurer, (vii) Stephen Kalinchak, Assistant Secretary, (viii) Colleen Proctor, Vice President and (ix) Thomas Grenier, Vice President.

Tools for this story

Each opens in a new tab, filled in for Dynavax Technologies Corp. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/dynavax-technologies
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Dynavax Technologies Corp? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/dynavax-technologies